<DOC>
	<DOCNO>NCT01085045</DOCNO>
	<brief_summary>The purpose study evaluate , 1 week dosing , efficacy safety PT003 compare individual component ( PT001 PT005 ) , placebo two active comparators demonstrate superiority combination component , assess relative contribution component compare placebo , patient moderate severe COPD .</brief_summary>
	<brief_title>Study Evaluate Efficacy , Safety Pharmacokinetics PT001 , PT003 , PT005 Following Chronic Dosing ( 7 Days ) Patients With Moderate Very Severe Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Signed write informed consent 40 80 year age Clinical history COPD airflow limitation fully reversible Females nonchild bear potential female child bear potential negative pregnancy test ; acceptable contraceptive method Current/former smoker least 10 packyear history cigarette smoke A measure post bronchodilator FEV1/FVC ratio &lt; = 0.70 A measure post bronchodilator FEV1 &gt; = 750ml 30 % predict &lt; = 80 % predict normal value Able change COPD treatment require protocol Women pregnant lactate Primary diagnosis asthma Alpha1 antitrypsin deficiency cause COPD Active pulmonary disease Prior lung volume reduction surgery Abnormal chest Xray ( CT scan ) due presence COPD Hospitalized due poorly control COPD within 3 month Screening Clinically significant medical condition preclude participation study ( e.g . clinically significant abnormal ECG , uncontrolled hypertension , glaucoma , symptomatic prostatic hypertrophy ) Cancer complete remission least 5 year Treatment investigational study drug participation another clinical trial study within last 30 day 5 half live Other protocol define inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>COPD</keyword>
</DOC>